| # | Drug | Count |
|---|---|---|
| 0 | SORAFENIB | 144 |
| 1 | BEVACIZUMAB | 61 |
| 2 | ATEZOLIZUMAB | 60 |
| 3 | NITISINONE | 52 |
| 4 | REGORAFENIB | 51 |
| 5 | CABOZANTINIB | 40 |
| 6 | RIBAVIRIN | 24 |
| 7 | ASPIRIN | 23 |
| 8 | ASPIRIN 325 MG | 23 |
| 9 | ASPIRIN 81 MG | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITISINONE | 52 | 0.0544 |
| 1 | SORAFENIB | 144 | 0.0070 |
| 2 | REGORAFENIB | 51 | 0.0044 |
| 3 | TREMELIMUMAB | 12 | 0.0027 |
| 4 | TAURINE | 2 | 0.0027 |
| 5 | LAMIVUDINE AND ZIDOVUDINE | 17 | 0.0022 |
| 6 | ENTECAVIR | 22 | 0.0019 |
| 7 | ATEZOLIZUMAB | 60 | 0.0015 |
| 8 | IVOSIDENIB | 2 | 0.0009 |
| 9 | UREA | 2 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 52 | 0.0630 |
| 1 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 2 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 3 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 2 | 0.0009 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 17 | 0.0008 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 37 | 0.0008 |
| 6 | Interferon gamma [EPC] | 1 | 0.0007 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 68 | 0.0007 |
| 8 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 9 | Protease Inhibitor [EPC] | 24 | 0.0005 |